Click for best price
Leukemia Molecular Diagnostics Market Size, Share 2023
A molecular approach for diagnosing leukemia
This report aims to provide a comprehensive presentation of the global market for Leukemia Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukemia Molecular Diagnostics. This report contains market size and forecasts of Leukemia Molecular Diagnostics in global, including the following market information:
Global Leukemia Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Leukemia Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Leukemia Molecular Diagnostics include Liferiver, Gpmedical, Zeesan, Mole, Berryoncology, Helixgen, Annoroad, Unitedgene and Inmedi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Leukemia Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Leukemia Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Leukemia Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Leukemia Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Leukemia Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Leukemia Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Leukemia Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Leukemia Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Leukemia Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Liferiver
Gpmedical
Zeesan
Mole
Berryoncology
Helixgen
Annoroad
Unitedgene
Inmedi
Qiagen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Leukemia Molecular Diagnostics, market overview.
Chapter 2: Global Leukemia Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Leukemia Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Leukemia Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Leukemia Molecular Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Leukemia Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Leukemia Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Leukemia Molecular Diagnostics Overall Market Size
2.1 Global Leukemia Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Leukemia Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Leukemia Molecular Diagnostics Players in Global Market
3.2 Top Global Leukemia Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Leukemia Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Leukemia Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Leukemia Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Leukemia Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Leukemia Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Leukemia Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Leukemia Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Leukemia Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Leukemia Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Leukemia Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Leukemia Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Leukemia Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Leukemia Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Leukemia Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Leukemia Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Leukemia Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Leukemia Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Leukemia Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Leukemia Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Leukemia Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Leukemia Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Leukemia Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Leukemia Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Leukemia Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Leukemia Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Leukemia Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Leukemia Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Leukemia Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Leukemia Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Leukemia Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Leukemia Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Leukemia Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Leukemia Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Leukemia Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Leukemia Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Leukemia Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Leukemia Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Leukemia Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Leukemia Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Leukemia Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Leukemia Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Leukemia Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Leukemia Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Leukemia Molecular Diagnostics Market Size, 2018-2030
7 Leukemia Molecular Diagnostics Companies Profiles
7.1 Liferiver
7.1.1 Liferiver Company Summary
7.1.2 Liferiver Business Overview
7.1.3 Liferiver Leukemia Molecular Diagnostics Major Product Offerings
7.1.4 Liferiver Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Liferiver Key News & Latest Developments
7.2 Gpmedical
7.2.1 Gpmedical Company Summary
7.2.2 Gpmedical Business Overview
7.2.3 Gpmedical Leukemia Molecular Diagnostics Major Product Offerings
7.2.4 Gpmedical Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Gpmedical Key News & Latest Developments
7.3 Zeesan
7.3.1 Zeesan Company Summary
7.3.2 Zeesan Business Overview
7.3.3 Zeesan Leukemia Molecular Diagnostics Major Product Offerings
7.3.4 Zeesan Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Zeesan Key News & Latest Developments
7.4 Mole
7.4.1 Mole Company Summary
7.4.2 Mole Business Overview
7.4.3 Mole Leukemia Molecular Diagnostics Major Product Offerings
7.4.4 Mole Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Mole Key News & Latest Developments
7.5 Berryoncology
7.5.1 Berryoncology Company Summary
7.5.2 Berryoncology Business Overview
7.5.3 Berryoncology Leukemia Molecular Diagnostics Major Product Offerings
7.5.4 Berryoncology Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Berryoncology Key News & Latest Developments
7.6 Helixgen
7.6.1 Helixgen Company Summary
7.6.2 Helixgen Business Overview
7.6.3 Helixgen Leukemia Molecular Diagnostics Major Product Offerings
7.6.4 Helixgen Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Helixgen Key News & Latest Developments
7.7 Annoroad
7.7.1 Annoroad Company Summary
7.7.2 Annoroad Business Overview
7.7.3 Annoroad Leukemia Molecular Diagnostics Major Product Offerings
7.7.4 Annoroad Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Annoroad Key News & Latest Developments
7.8 Unitedgene
7.8.1 Unitedgene Company Summary
7.8.2 Unitedgene Business Overview
7.8.3 Unitedgene Leukemia Molecular Diagnostics Major Product Offerings
7.8.4 Unitedgene Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Unitedgene Key News & Latest Developments
7.9 Inmedi
7.9.1 Inmedi Company Summary
7.9.2 Inmedi Business Overview
7.9.3 Inmedi Leukemia Molecular Diagnostics Major Product Offerings
7.9.4 Inmedi Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Inmedi Key News & Latest Developments
7.10 Qiagen
7.10.1 Qiagen Company Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Leukemia Molecular Diagnostics Major Product Offerings
7.10.4 Qiagen Leukemia Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Qiagen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Leukemia Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Leukemia Molecular Diagnostics Market Drivers in Global Market
Table 3. Leukemia Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Leukemia Molecular Diagnostics in Global Market
Table 5. Top Leukemia Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Leukemia Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Leukemia Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Leukemia Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Leukemia Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Leukemia Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Leukemia Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Leukemia Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Leukemia Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Leukemia Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Leukemia Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Leukemia Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Liferiver Company Summary
Table 31. Liferiver Leukemia Molecular Diagnostics Product Offerings
Table 32. Liferiver Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Liferiver Key News & Latest Developments
Table 34. Gpmedical Company Summary
Table 35. Gpmedical Leukemia Molecular Diagnostics Product Offerings
Table 36. Gpmedical Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Gpmedical Key News & Latest Developments
Table 38. Zeesan Company Summary
Table 39. Zeesan Leukemia Molecular Diagnostics Product Offerings
Table 40. Zeesan Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Zeesan Key News & Latest Developments
Table 42. Mole Company Summary
Table 43. Mole Leukemia Molecular Diagnostics Product Offerings
Table 44. Mole Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Mole Key News & Latest Developments
Table 46. Berryoncology Company Summary
Table 47. Berryoncology Leukemia Molecular Diagnostics Product Offerings
Table 48. Berryoncology Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Berryoncology Key News & Latest Developments
Table 50. Helixgen Company Summary
Table 51. Helixgen Leukemia Molecular Diagnostics Product Offerings
Table 52. Helixgen Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Helixgen Key News & Latest Developments
Table 54. Annoroad Company Summary
Table 55. Annoroad Leukemia Molecular Diagnostics Product Offerings
Table 56. Annoroad Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Annoroad Key News & Latest Developments
Table 58. Unitedgene Company Summary
Table 59. Unitedgene Leukemia Molecular Diagnostics Product Offerings
Table 60. Unitedgene Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Unitedgene Key News & Latest Developments
Table 62. Inmedi Company Summary
Table 63. Inmedi Leukemia Molecular Diagnostics Product Offerings
Table 64. Inmedi Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Inmedi Key News & Latest Developments
Table 66. Qiagen Company Summary
Table 67. Qiagen Leukemia Molecular Diagnostics Product Offerings
Table 68. Qiagen Leukemia Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Qiagen Key News & Latest Developments
List of Figures
Figure 1. Leukemia Molecular Diagnostics Segment by Type in 2022
Figure 2. Leukemia Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Leukemia Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Leukemia Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Leukemia Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Leukemia Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Leukemia Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Leukemia Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Liferiver Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gpmedical Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Zeesan Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Mole Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Berryoncology Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Helixgen Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Annoroad Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Unitedgene Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Inmedi Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Qiagen Leukemia Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
